Sanolla Wins Horizon 2020 Funding to Fight COVID-19 with Early Detection and Monitoring Technology
Sanolla, an Israeli medical device and technology start-up driving artificial intelligence (AI) based innovations in acoustic digital diagnostic systems and healthcare platforms, has been granted EU funding under the Horizon 2020 program to help tackle the ongoing coronavirus (COVID-19) pandemic.
Following its previous announcement, Sanolla shifted its technology to support the early detection and monitoring of COVID-19 allowing doctors to rapidly assess and diagnose patients with its artificial intelligence-based smart auscultation device. Sanolla set up a consortium consisting of seven European entities and companies. As a leader of the consortium, Sanolla and its partners have been granted a total of €5 million funding for the project, under the Horizon 2020 program designed to fight COVID-19.
Achieving a perfect score of 15 out of 15, given by all EU examiners, Sanolla’s proposal earned outstanding mention in the program.
“Effective remote patient monitoring is critical in the battle against COVID-19. This technology allows for the collection of important clinical information,” stated Dr. Michael Wasserman, MD, CMD, President of the California Association of Long-Term Care Medicine and a member of the National Academy of Science Committee for developing a Framework for Equitable Allocation of Vaccine for COVID-19.
“I am proud that our technology and products can help the world in fighting the COVID-19 pandemic,” added Dr. Doron Adler, the Chairman, Founder & CEO. “Given the terms of submission and the urgent demand for fast-moving solutions, we were extremely pleased to learn that the program understood the significant impact that our infrasound-based AI technology can have on the early detection and monitoring of COVID-19. We are grateful for the confidence put in us and are fully committed to working hard to bring to market our instant diagnostic tools to fight the COVID-19 pandemic.”